NCT03775239

Brief Summary

The primary aim of this study is to test Mindfulness in Sex Therapy and Intimate Relationships (MSIR) as an add-on treatment to sex therapy in a clinical sample of patients referred with sexual problems, controlling for time effect, with a treatment as usual activity group. The secondary aim is to investigate the effect of MSIR alone on sexual dysfunction compared to treatment-as-usual (TAU). It is hypothesized that the MSIR group, in preceding the usual TAU intervention, will achieve greater benefits in relation to sexual functioning outcomes as measured by subjective and objective measures. The investigators expect that MSIR will help the patients to cultivate accept and body awareness, which will create a wider sense of safety and stability that might help integrating the assistant provided by the traditional approach to the treatment of sexual dysfunctions. It is hypothesized that the intervention (MSIR+TAU) reduces the amount of TAU sessions needed in order to achieve a benefit in terms of the patient's sexual dysfunction. It is furthermore, hypothesized that the intervention (MSIR) alone will have a positive effect on the sexual dysfunction. The research project outlines a pragmatic pilot randomized control trial to evaluate MSIR treatment as an add-on to the treatment-as-usual (TAU) compared to TAU for sexual difficulties in men and women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

December 13, 2018

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 19, 2022

Completed
Last Updated

February 3, 2023

Status Verified

December 1, 2022

Enrollment Period

4.4 years

First QC Date

September 14, 2018

Last Update Submit

February 2, 2023

Conditions

Keywords

Desire dysfunctionErectile dysfunctionOrgasm dysfunctionSexual painHyper sexualityMindfulness

Outcome Measures

Primary Outcomes (5)

  • The Sexual Function Questionnaire for Females & Males (CSFQ-14-F/M)

    The CSFQ is a 14 item self-report inventory which measures sexual functioning on a 5 point likert scale. The questionnaire comprises: a 5 scale structure consistent with the original (longer) CSFQ - Desire/Frequency, Desire/Interest, Arousal/Excitement, Orgasm/Completion, Pleasure, The questionnaire has a high degree of internal consistency as a whole (Cronbach's alpha = 0.90 for females and 0.89 for males) and for the individual scales (all were between 0.68 and 0.84, except the male orgasm/completion scale, 0.59). Good scale coherency and discrimination was demonstrated by highly significant mean difference scores between the CSFQ and control groups.

    Change from baseline CSFQ score to 6 month follow-up CSFQ score

  • Female Sexual Function Index (FSFI)

    The Female Sexual Function Index (FSFI) is a validated 19-item multidimensional self-report instrument for the assessment of female sexual function that comprise a full scale and six subscales (desire, arousal, lubrication, orgasm, satisfaction and pain). It measures the overall sexual function through either 0-5 or 1-5-point Likert scales. A higher score represents better sexual function. A score equal to or below 26.55 points represents a risk of sexual dysfunction. The FSFI has shown test-retest reliability (r=0,75-0,86). The scale is recommended for clinical practice as a measure of symptoms severity in women who have been sexually active in the prior 4 weeks51 and is the golden standard when measuring sexual function in women

    Change from baseline FSFI score to 6 month follow-up FSFI score

  • Female Sexual Distress Scale (FSDS)

    The Female Sexual Distress Scale (FSDS) is a validated 12-item self-administered questionnaire, developed to measure sexually related personal distress in women. Lower scores represent less sexual distress. Scores equal to or above 15 points indicates sexually related distress.

    Change from baseline FSDS score to 6 month follow-up FSDS score

  • The International Index of Erectile Function (IIEF)

    The IIEF is a validated self-administered 15-item questionnaire that asses male sexual function. The IIEF-questionnaire seeks to detect treatment-related changes in patients with erectile functions and is the golden standard. The IIEF comprises a full scale and five subdomains (erectile function, orgasmic function, sexual desire, intercourse satisfaction and overall satisfaction). A low score represents worse sexual function. The questionnaire comprises a full scale and five subdomains. The subdomains are; erectile function; orgasmic function; sexual desire; intercourse satisfaction; and overall satisfaction).

    Change from baseline IIEF score to 6 month follow-up IIEF score

  • Bothered by Problem (VAS)

    Single-item distress scale measuring on a Likert scale from 1-10 (10 is most distressed) distress by the problem which the person sought help for. "How bothered are you at this time of the problem you are/were seeking for help for?"

    Change from baseline VAS score to 6 month follow-up VAS score

Secondary Outcomes (4)

  • The Five Facet Mindfulness Questionnaire (FFMQ)

    1 time a week after mindfulness session up to 8 weeks

  • The Multidimensional Assessment of Interoceptive Awareness (MAIA)

    Week 0, week 3,6,9,month 6

  • World Health Organization 5 Wellbeing Questionnaire (WHO-5)

    Week 0, week 3,6,9,month 6

  • The Symptom Checklist (SCL-10)

    Week 0, week 3,6,9,month 6

Other Outcomes (1)

  • Questionnaire to collect individual demographic data

    Week 0 and month 6.

Study Arms (2)

Treatment-as-usual

OTHER

Those who are randomly selected to treatment-as-usual will receive a minimum of 6 sessions at Sexological Clinic.

Behavioral: Treatment-as-usual

Treatment-as-usual + MSIR

OTHER

Those who are randomly selected to receive Mindfulness in Sex Therapy and Intimate Relationships (MSIR) will first receive 6 weeks of mindfulness followed by treatment-as-usual. The intervention will take place at Sexological Clinic.

Behavioral: Mindfulness in Sex Therapy and Intimate Relationships (MSIR)Behavioral: Treatment-as-usual

Interventions

Mindfulness is a mental discipline inviting intentional, non-judgmental attending of the stream of experience. Mindfulness can be seen as an adjunct to sexual therapy. Firstly, it is a way of teaching the patients and the couples to carry out sensate focus so that it can achieve its goals. Beyond this, Mindfulness may invite a stance to one's own and a partner's physical and emotional experience that is more widely beneficial. The MSIR intervention was originally developed from the Mindfulness Based Cognitive Therapy (MBCT) protocol and consists of: Week 1: Moving into the Body Week 2: Sensing \& Exploring Week 3: Avoidance \& Intimacy- Midway individual session. Week 4: Recognising our automatic mind Week 5: Spacious Awareness Week 6: Expanding new learning

Treatment-as-usual + MSIR

The current treatment in Sexological Clinic is an eclectic, synthetic therapy form conducted by psychiatrists, other medical doctors, psychologists and bodytherapists. In order to implement the bio-psycho-social character of sexual dysfunctions, the current treatment takes advantage of different elements from different therapy forms combined with pharmacological treatment if necessary. The integrated treatment combines elements from therapy's such as cognitive behavioural therapy (CBT), psychodynamic therapy and systemic therapy together with Master and Johnson's sensate focus training, body exercises training as pelvis floor exercises, introduction of sexual aids and if necessary pharmacological treatment. The therapy can be individual treatment, couple therapy (marital therapy) or group therapy.

Treatment-as-usualTreatment-as-usual + MSIR

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 20-65 years referred to Sexological Clinic and diagnosed with sexual dysfunction (desire dysfunction, erectile dysfunction, orgasm dysfunction, sexual pain or hyper sexuality).
  • After assessment, being allocated to individual or couple therapy for their sexual dysfunction. The partner will be included in case of couples therapy
  • Allocated to a minimum of 6 treatment sessions in TAU after assessment
  • Giving informed consent
  • Being able to read, write, speak and understand the Danish language.

You may not qualify if:

  • Assessed for group therapy
  • Cannot participate at the scheduled MSIR session due for practical reasons
  • Having experienced sexual trauma in the past, suffering from mental illness, severe somatic disease and/or addiction
  • Withdrawing their informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sexological Clinic

Copenhagen, 2200, Denmark

Location

MeSH Terms

Conditions

Sexual Dysfunction, PhysiologicalSexual Dysfunctions, PsychologicalErectile Dysfunction

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesMental DisordersGenital Diseases, MaleMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 14, 2018

First Posted

December 13, 2018

Study Start

July 25, 2018

Primary Completion

December 1, 2022

Study Completion

December 19, 2022

Last Updated

February 3, 2023

Record last verified: 2022-12

Locations